UAEM is supporting the efforts by the Canadian HIV/AIDS Legal Network to reform Canada's Access to Medicines Regime (CAMR), patent legislation intended to allow generic Canadian production of patented medications for export to poor countries, but underused due to excessive red tape.
[Read More]